Two potential return-on-investment results are: (a) +0.6% absolute return-on-investment (equivalent to +33.0% annualized
return-on-investment for the next 7 days) if the stock is assigned early (on the last trading day prior to the March 14th, 2022 ex-dividend date); OR (b) +1.3%
absolute return (equivalent to +31.0% annualized return over the next 15 days) if the stock is assigned on the March 22nd options expiration date.
The simultaneous buy/write transaction was as follows:
3/7/2024 Bought 200 shares of Merck & Co. stock @ $123.76 per share.
3/7/2024 Sold 2 MRK March 22nd, 2024 $121.00 Call options @ $3.52 per share.
3/14/2024 Upcoming ex-dividend of $.77 per share
Two possible overall performance results (including commissions) would be as follows:
Covered Calls Net Investment: $24,049.34
= ($123.76 - $3.52) * 200 shares + $1.34 commission Net Profit Components:
(a) Options Income: +$704.00
= ($3.52 * 200 shares)
(b) Dividend Income (If Merck shares assigned on 3/13/2024, the business day prior to the 3/14/2024 ex-dividend date): = +$0.00; or
(b) Dividend Income (If Merck shares assigned at 3/22/2024 options expiration): +$154.00
= $.77 per share x 200 shares
(c) Capital Appreciation (If MRK shares assigned early on 3/13/2024): -$552.00
= ($121.00 strike price -$123.76 stock purchase price) * 200 shares; or
(c) Capital Appreciation (If MRK shares assigned with stock above the $121.00 strike price at the March 22nd options expiration): -$552.00
= ($121.00 -$123.76) * 200 shares
1. Potential Net Profit (If Merck shares assigned on 3/13/2024, the day prior to the March 14th ex-dividend date): +$152.00
= (+$704.00 options income +$0.00 dividend income - $552.00 capital appreciation)
2. Potential Net Profit (If MRK price is above $121.00 strike price at the March 22nd options expiration): +$306.00
= (+$704.00 options income +$154.00 dividend income - $552.00 capital appreciation)
1. Absolute Return-on-Investment (If Merck shares assigned early on 3/13/2024, the day prior to the March 14th, 2024 ex-dividend date): +0.6%
= +$152.00/$24,049.34
Equivalent Annualized Return-on-Investment (If assigned early on day prior to ex-div date): +33.0%
= (+$152.00/$24,049.34) * (365/7 days)
2. Absolute Return-on-Investment (If Merck price is above $121.00 strike price at the March 22nd options expiration): +1.3%
= +$306.00/$24,049.34
Equivalent Annualized Return-on-Investment (If assigned on 3/22/2024 options expiration date): +31.0%
= (+$306.00/$24,049.34) * (365/15 days)
At least eight of the nine metrics used in the Covered Calls Advisor's Dividend Capture Strategy spreadsheet (see below) must be 'YES' prior to establishing a new Covered Calls position using the Covered Calls Advisor's Dividend Capture strategy. As shown below, all nine criteria are achieved for this Merck & Co. Inc. Covered Calls position.